|
11
|
|
Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma.
(linkinghub.elsevier.com)
|
Wang S
…
Mouliere F
Cell Reports Medicine
2026-08-24
|
#cell-free dna
#lymphoma
#sequencing
#biomarker
#prognosis
|
|
8
|
|
SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.
(pnas.org)
|
Hill KK
…
Luftig MA
PNAS
2026-08-24
|
#metabolism
#ebv
#lymphoma
#deacetylase
#immunology
|
|
0
|
|
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.
(nature.com)
|
Paruzzo L
…
Ruella M
Nature Medicine
2026-08-10
|
#car-t
#lymphoma
#persistence
#immunotherapy
#transcriptomics
|
|
0
|
|
Therapeutic outcomes of TP53-mutated diffuse large B cell lymphoma: A systematic review and meta-analysis.
(linkinghub.elsevier.com)
|
Zhou X
…
Shan N
iScience
2026-08-06
|
#lymphoma
#immunotherapy
#chemotherapy
#mutation
#prognosis
|
|
0
|
|
High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma.
(nature.com)
|
Pages-Geli C
…
Weiskopf K
Nature Communications
2026-08-01
|
#antibody
#immunotherapy
#lymphoma
#macrophage
#cytotoxicity
|
|
0
|
|
Classic Hodgkin Lymphoma: A Review.
(jamanetwork.com)
|
Patel KK
…
Moskowitz AJ
JAMA
2026-08-03
|
#lymphoma
#oncology
#hematology
#malignancy
#immunosuppression
|
|
0
|
|
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.
(linkinghub.elsevier.com)
|
Song C
…
Wang H
Drug Resistance Updates
2026-07-31
|
#immunotherapy
#lymphoma
#amr
#metabolism
#xenograft
|
|
0
|
|
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.
(nature.com)
|
Yousefian S
…
Haas S
Nature Communications
2026-07-29
|
#immunotherapy
#lymphoma
#t-cells
#biomarker
#phenotyping
|